Health Care Reform and Possible Effects on Innovative Therapies: Cancer as a Case Study : Hearing Before the Subcommittee on Technology, Environment, and Aviation of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, Second Session, February 2, 1994, Volume 4U.S. Government Printing Office, 1994 - 198 pages |
Other editions - View all
Common terms and phrases
administration Administration's antibody areas biotech biotech companies biotech firms biotechnology companies biotechnology industry Biotechnology Industry Organization bone marrow transplant breakthrough drugs breast cancer CANCE cancer cells cancer patients capital Chairman chemotherapy clinical trials Clinton colon cancer colorectal cancer committee competition Congress Curd cures disease doctors drug companies drug costs drug prices effective Federal FELDBAUM funding gene therapy Genentech Genzyme global going health care costs health care reform health care system HOKE hospital human impact increased innovation investment investors issue Japan Johnson KLEIN manufacturing medical device medical device industry medicine million National Cancer Institute overutilization percent pharmaceutical industry prescription President price controls Price Regulation profits proposed protein receptor regulatory research and development result risk spending subcommittee surgery Thank therapeutic Tim Valentine treat TREATMENT OF COLORECTAL tumor United VALENTINE WAGNER-JOHNSON women